Novel Compounds
    9.
    发明申请
    Novel Compounds 审中-公开
    新型化合物

    公开(公告)号:US20090012011A1

    公开(公告)日:2009-01-08

    申请号:US12160473

    申请日:2007-01-11

    CPC分类号: C07D409/12

    摘要: This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain substituted pyrrolidines, according to Formula ISpecifically, the invention is directed to compounds according to Formula I wherein R1 is H or C1-C6 alkyl; R2 is H or OH; and R3 is an optionally substituted aryl.

    摘要翻译: 本发明涉及可用于治疗与TRPV4通道受体相关的疾病的新化合物。 更具体地,本发明涉及根据式I的某些取代的吡咯烷。具体地,本发明涉及式I的化合物,其中R 1是H或C 1 -C 6烷基; R2是H或OH; 并且R 3是任选取代的芳基。

    Novel Compounds
    10.
    发明申请
    Novel Compounds 审中-公开
    新型化合物

    公开(公告)号:US20080318945A1

    公开(公告)日:2008-12-25

    申请号:US12097114

    申请日:2006-12-15

    摘要: This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain substituted piperazines, according to Formula IA compound of formula I wherein Z is bond or NH; R1 is aryl or optionally substituted heteroaryl; R2 is H, optionally substituted C1-6alkyl, or optionally substituted C2-6alkenyl; R3 and R7 are independently H, optionally substituted C1-6alkyl, or aryl; R4 is H or optionally substituted C1-6alkyl; R5 is H or C1-6alkyl; R6 is H or C1-6alkyl; and X and X′ are independently O or H2; or wherein R3 and R4 together form a part of morpholinyl, piperadinyl, or aziridinyl ring; and pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明涉及可用于治疗与TRPV4通道受体相关的疾病的新化合物。 更具体地,本发明涉及根据式I的某些取代的哌嗪其中Z是键或NH的式I化合物; R1是芳基或任选取代的杂芳基; R2是H,任选取代的C 1-6烷基,或任选取代的C 2-6烯基; R3和R7独立地为H,任选取代的C 1-6烷基或芳基; R4是H或任选取代的C 1-6烷基; R5是H或C1-6烷基; R6是H或C1-6烷基; X和X'独立地为O或H 2; 或其中R3和R4一起形成吗啉基,哌啶基或氮丙啶基环的一部分; 及其药学上可接受的盐。